Neurophysiologic Biomarkers in Neuropsychiatric Disorders Etiologic and Treatment Considerations /
This book reviews neurophysiological biomarkers in neuropsychiatric disorders from the viewpoint of the 21st Century Cures Act, which encourages the use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomar...
Uloženo v:
| Korporativní autor: | |
|---|---|
| Další autoři: | , |
| Médium: | Elektronický zdroj E-kniha |
| Jazyk: | angličtina |
| Vydáno: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2024.
|
| Vydání: | 1st ed. 2024. |
| Edice: | Advances in Neurobiology,
40 |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/978-3-031-69491-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Obsah:
- Introduction to volume: Biomarkers in Psychiatry
- Part I: Government and Pharma perspectives on biomarker development
- Biomarker Methodologies: a NIMH Perspective
- Neural Circuitry-related biomarkers for drug development in psychiatry – An industry perspective
- Public Private Partnerships for Neuropsychiatric Drug Development: A Perspective
- Part II: Biomarker methodologies and Translational Approaches
- Methods for and use of functional magnetic resonance imaging in psychiatry
- Advanced methodology for neurophysiological analysis and biomarker development: time-frequency and source-localization approaches
- Magnetoencephalography in Psychiatry: A Perspective on Translational Research and Applications
- Modern methods for unraveling cell- and circuit-level mechanisms of neurophysiological biomarkers in psychiatry
- Rodent models for ASD biomarker development
- Auditory biomarkers of neuropsychiatric disorders in nonhuman primates
- Part III: Biomarkers in schizophrenia and clinical high risk
- Functional Connectivity Biomarkers in Schizophrenia
- The use of event-related potentials in the study of schizophrenia: An overview
- Gamma Oscillations as a Biomarker of Neural Circuit Function in Psychosis: Where Are We, and Where Do We Go from Here?
- Altered sleep oscillations as neurophysiological biomarkers of schizophrenia
- Neurophysiological models in individuals at clinical high risk for psychosis: Using translational EEG paradigms to forecast psychosis risk and resilience
- Mismatch negativity (MMN) as a pharmacodynamic/response biomarker for NMDA receptor- and excitatory/inhibitory imbalance-targeted treatments in schizophrenia
- Part IV: Biomarkers in ASD
- Towards Biomarkers for Autism Spectrum Disorder: Contributions of Magnetoencephalography (MEG)
- Structural Brain Imaging Biomarkers of Autism Spectrum Disorder
- Delineating a pathway for the discovery of functional connectome biomarkers of autism
- EEG Biomarkers for Autism : Rational, Support, and the Qualification Process
- Part V: Other disorders
- Translating decades of neuroscience research into diagnostic and treatment biomarkers for ADHD
- Neuroimaging Biomarkers in Parkinson’s Disease
- Biomarkers of Auditory-Verbal Hallucinations
- Part VI: Cross-diagnostic methodologies
- Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes
- Biomarkers for cognitive control, response inhibition, aggressivity, impulsivity and violence
- Visual neurophysiological biomarkers for patient stratification and treatment development across neuropsychiatric disorders
- The less things change, the more they remain the same: Impaired neural plasticity as a critical target for drug development in neuropsychiatry.